Search Browse Earnings

ALUMIS INC. — SlamSEC

ALUMIS INC.

Nasdaq:ALMS

Pharmaceutical Preparations·SOUTH SAN FRANCISCO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$156.9M

FY 2024

Net Income

-$155.0M

FY 2024

EPS (Diluted)

-$72.08

FY 2024

Stock Price

$28.10

+4.6%

2026-03-10

52W Range

$2.76 – $30.60

P/E Ratio

-0.4x

Market Cap

—

Cash

$46.0M

FY 2024

Total Debt

—

Net Cash

$46.0M

Enterprise Value

—

Debt / EBITDA

0.3x

FY 2024

EV / EBITDA

—

Employees

—